US Patent 11344610 Prevention and reduction of blood loss
Patent 11344610 was granted and assigned to Takeda Pharmaceutical Company on May, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11344610 Prevention and reduction of blood loss
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
